Results 1-3 of 3 (Search time: 0.004 seconds).
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial (Journal article)
Cancer of unknown primary patients with midline nodal distribution: midway between poor and favourable prognosis? (Journal article)
Prognostic utility of beta-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study (Journal article)